Table 4.
DR | NDR | Control | P | |
---|---|---|---|---|
EGF | 2.10 ± 1.92 | 1.87 ± 1.37 | 2.78 ± 1.57 | 0.193 |
FGF-2/FGF basic | 25.83 ± 12.79 | 32.36 ± 14.20 | 25.90 ± 8.51 | 0.194 |
HGF | 1327.16 ± 1250.12 | 474.48 ± 267.76 | 284.67 ± 217.93 | <0.001* |
β-NGF | 19.73 ± 14.09 | 20.51 ± 11.43 | 25.87 ± 11.90 | 0.305 |
PDGF-BB | 15.41 ± 14.35 | 14.44 ± 20.79 | 18.74 ± 24.66 | 0.815 |
PLGF | 12.59 ± 2.52 | 11.50 ± 1.66 | 12.33 ± 1.94 | 0.281 |
VEGF-A | 357.02 ± 84.25 | 373.87 ± 226.73 | 238.02 ± 192.41 | 0.039* |
VEGF-D | 5.97 ± 5.20 | 3.81 ± 3.43 | 4.88 ± 3.34 | 0.356 |
Data are expressed as the mean ± SD (pg/ml)
EGF epidermal growth factor, FGF fibroblast growth factor, HGF hepatocyte growth factor, NGF Nerve Growth Factor, PDGF platelet derived growth factor, PLGF placental growth factor, VEGF vascular endothelial growth factor
* p < 0.05